Mereo BioPharma Group plc
MREO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $70 | $57 | $68 | $127 |
| Short-Term Investments | $0 | $0 | $0 | $1 |
| Receivables | $3 | $4 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2 | $3 | $7 | $7 |
| Total Curr. Assets | $75 | $64 | $75 | $134 |
| Property Plant & Equip (Net) | $1 | $2 | $2 | $3 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $1 | $1 | $0 | $33 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $2 | $3 | $2 | $37 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $76 | $66 | $77 | $171 |
| Liabilities | – | – | – | – |
| Payables | $2 | $2 | $3 | $3 |
| Short-Term Debt | $6 | $1 | $14 | $1 |
| Tax Payable | $1 | $1 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $4 | $6 | $7 | $13 |
| Total Curr. Liab. | $14 | $9 | $24 | $17 |
| LT Debt | $0 | $5 | $1 | $22 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $1 | $0 | $13 |
| Total NC Liab. | $2 | $6 | $2 | $35 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $2 | $2 | $3 |
| Total Liabilities | $15 | $16 | $26 | $52 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $3 | $3 | $2 | $2 |
| Retained Earnings | -$463 | -$420 | -$405 | -$402 |
| AOCI | -$19 | -$17 | -$22 | $184 |
| Other Equity | $540 | $485 | $475 | $335 |
| Total Equity | $61 | $51 | $51 | $119 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $76 | $66 | $77 | $171 |
| Net Debt | -$63 | -$51 | -$53 | -$104 |